{"id":72103,"date":"2024-07-30T11:11:35","date_gmt":"2024-07-30T11:11:35","guid":{"rendered":"https:\/\/chezaspin.com\/blog\/index.php\/2024\/07\/30\/usaid-to-continue-funding-kenya-in-developing-its-vaccine-manufacturing-plant\/"},"modified":"2024-07-30T11:11:35","modified_gmt":"2024-07-30T11:11:35","slug":"usaid-to-continue-funding-kenya-in-developing-its-vaccine-manufacturing-plant","status":"publish","type":"post","link":"https:\/\/chezaspin.com\/blog\/usaid-to-continue-funding-kenya-in-developing-its-vaccine-manufacturing-plant\/","title":{"rendered":"USAID to continue funding Kenya in developing its vaccine manufacturing plant"},"content":{"rendered":"<p><strong>MUNICH, Germany, Jul 30 \u2013 The United States Agency for International Development (USAID) will continue funding Kenya\u00a0 to help the country in developing its own vaccine manufacturing capabilities despite its lower-middle income status.<\/strong><\/p>\n<p>USAID also reaffirmed Its donor funding\u00a0 for manufacturing of vaccines in other\u00a0 African countries in boosting vaccine manufacturing capacity. These counties are also going to receive funds from their governments and private investors because of their earned\u00a0 lower-middle level status.<\/p>\n<p>Speaking in Munich during the 2024 International AIDS Conference, USAID Assistant Administrator for Global Health Atul Gawande in an interview with Capital FM said\u00a0 USAID has put funds for the manufacturing of diagnostics of medicines and vaccines in Kenya.<\/p>\n<p>\u00a0 Kenya is building\u00a0 its infrastructure and expertise in vaccine production at the Kenya BioVax Institute to formulate and package vaccines by 2029\u00a0 making the country more self-sufficient in public health.<\/p>\n<p>\u201cKenya has become a place that nurtures donor governments but investors all over the world are making debts, some debts will not work and others will work\u00a0 but we have seen increased funding coming to\u00a0 kenya manufacturing\u00a0 for that reason,\u201d Said Gawande.<\/p>\n<p>He noted, they are working with the Kenyan government in supporting the primary healthcare systems\u00a0 and empowering community health workers with training and support.<\/p>\n<p>Gawande added, the US merged with Global Alliance for Vaccines and Immunization(\u00a0 GAVI) and African Vaccine Alliance Accelerator this will monitor the vaccine companies that have come together that have an approved WHO prequalified vaccine.<\/p>\n<p>These vaccines will include oral routine chapter vaccines and companies that will meet the Prequalification in Africa will get a payment of 20 to 50 million dollars depending on the strength of their approval in manufacturing the substance itself.<\/p>\n<p>They will also get paid a subsidized price so that it centralizes the production in these counties.<\/p>\n<p>\u201cone kind of financing might be reduced and other kinds of financing are increasing and this is the pathway from low income to middle income\u00a0 and finally upper countries.<\/p>\n<p>Through global funding\u00a0 the life expectancy in kenya is 72 years\u00a0 after the start of the HIV and TB programs\u00a0 in the year 2000 when barely people made it to 60 years of age. \u201cthe US life expectancy is 78 so we are this close,\u201d said Gawande.<\/p>\n<p>\u201cwe are working with Kenya in building a manufacturing center to enable production of medicines and diagnosis\u00a0 vaccines to support the primary healthcare system and empowering community health workers with tools,\u201d said Gawande<\/p>\n<p>The Global Alliance for Vaccines and Immunization(GAVI) and UNICEF have been supporting the Kenya National vaccination programme.\u00a0 They have been giving Kenya at least sh. 32 billion every year since 2001.<\/p>","protected":false},"excerpt":{"rendered":"<p>MUNICH, Germany, Jul 30 \u2013 The United States Agency for International Development (USAID) will continue funding Kenya\u00a0 to help the country in developing its own vaccine manufacturing capabilities despite its lower-middle income status. USAID also reaffirmed Its donor funding\u00a0 for manufacturing of vaccines in other\u00a0 African countries in boosting vaccine manufacturing capacity. These counties are [&hellip;]<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-72103","post","type-post","status-publish","format-standard","hentry","category-uncategorized","entry"],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","jetpack-related-posts":[],"_links":{"self":[{"href":"https:\/\/chezaspin.com\/blog\/wp-json\/wp\/v2\/posts\/72103","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/chezaspin.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/chezaspin.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/chezaspin.com\/blog\/wp-json\/wp\/v2\/comments?post=72103"}],"version-history":[{"count":0,"href":"https:\/\/chezaspin.com\/blog\/wp-json\/wp\/v2\/posts\/72103\/revisions"}],"wp:attachment":[{"href":"https:\/\/chezaspin.com\/blog\/wp-json\/wp\/v2\/media?parent=72103"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/chezaspin.com\/blog\/wp-json\/wp\/v2\/categories?post=72103"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/chezaspin.com\/blog\/wp-json\/wp\/v2\/tags?post=72103"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}